These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35349833)
1. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis. Ye Y; Zhu YT; Xin XY; Zhang JC; Zhang HL; Li D Phytomedicine; 2022 Jun; 100():154072. PubMed ID: 35349833 [TBL] [Abstract][Full Text] [Related]
2. The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis. Ye Y; Zhu YT; Tong HX; Han JY Front Pharmacol; 2020; 11():615166. PubMed ID: 33424615 [No Abstract] [Full Text] [Related]
3. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis. Dong MX; Hu QC; Shen P; Pan JX; Wei YD; Liu YY; Ren YF; Liang ZH; Wang HY; Zhao LB; Xie P PLoS One; 2016; 11(7):e0158848. PubMed ID: 27387385 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Agents for tPA-Induced Cerebral Hemorrhage: A Systematic Review and Meta-Analysis of Preclinical Studies. Ye Y; Zhang FT; Wang XY; Tong HX; Zhu YT J Am Heart Assoc; 2020 Dec; 9(24):e017876. PubMed ID: 33283576 [TBL] [Abstract][Full Text] [Related]
5. Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol. Wu J; Wang L; Dong X; Li Z; Wang K; Li L; Liu J Medicine (Baltimore); 2021 Mar; 100(10):e25004. PubMed ID: 33725879 [TBL] [Abstract][Full Text] [Related]
7. Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin. Goncalves A; Su EJ; Muthusamy A; Zeitelhofer M; Torrente D; Nilsson I; Protzmann J; Fredriksson L; Eriksson U; Antonetti DA; Lawrence DA Blood; 2022 Jul; 140(4):388-400. PubMed ID: 35576527 [TBL] [Abstract][Full Text] [Related]
8. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke. Li C; Zhang L; Wang C; Teng H; Fan B; Chopp M; Zhang ZG Stroke; 2019 Sep; 50(9):2547-2554. PubMed ID: 31387512 [TBL] [Abstract][Full Text] [Related]
10. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341 [TBL] [Abstract][Full Text] [Related]
11. Extension of the thrombolytic time window with minocycline in experimental stroke. Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459 [TBL] [Abstract][Full Text] [Related]
12. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke. Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models. Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis. Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysis. Al-Salihi MM; Saha R; Ayyad A; Al-Jebur MS; Al-Salihi Y; Roy A; Dalal SS; Rivet D; Spiotta AM; Qureshi AI Clin Neurol Neurosurg; 2024 Jan; 236():108097. PubMed ID: 38176219 [TBL] [Abstract][Full Text] [Related]
16. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke. Li M; Chen S; Shi X; Lyu C; Zhang Y; Tan M; Wang C; Zang N; Liu X; Hu Y; Shen J; Zhou L; Gu Y J Neuroinflammation; 2018 Aug; 15(1):237. PubMed ID: 30139371 [TBL] [Abstract][Full Text] [Related]
17. Predictive model for the risk of hemorrhagic transformation after rt-PA intravenous thrombolysis in patients with acute ischemic stroke: A systematic review and meta-analysis. Zhong K; An X; Kong Y; Chen Z Clin Neurol Neurosurg; 2024 Apr; 239():108225. PubMed ID: 38479035 [TBL] [Abstract][Full Text] [Related]
18. Early ischemic blood brain barrier damage: a potential indicator for hemorrhagic transformation following tissue plasminogen activator (tPA) thrombolysis? Jin X; Liu J; Liu W Curr Neurovasc Res; 2014; 11(3):254-62. PubMed ID: 24875486 [TBL] [Abstract][Full Text] [Related]
20. In silico study of combination thrombolytic therapy with alteplase and mutant pro-urokinase for fibrinolysis in ischemic stroke. Yang Y; Gu B; Xu XY Comput Biol Med; 2024 Mar; 171():108141. PubMed ID: 38367449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]